
### [MONDO:0000762](http://purl.obolibrary.org/obo/MONDO_0000762)
**Label:** chromosomal duplication syndrome

**Subclasses:** [MONDO:0013298](http://purl.obolibrary.org/obo/MONDO_0013298) (chromosome 17q21.31 duplication syndrome), [MONDO:0012020](http://purl.obolibrary.org/obo/MONDO_0012020) (chromosome 22q11.2 microduplication syndrome), [MONDO:0013796](http://purl.obolibrary.org/obo/MONDO_0013796) (chromosome 17q12 duplication syndrome), [MONDO:0013273](http://purl.obolibrary.org/obo/MONDO_0013273) (chromosome 16p13.3 duplication syndrome), [MONDO:0012761](http://purl.obolibrary.org/obo/MONDO_0012761) (chromosome 3q29 microduplication syndrome), [MONDO:0012081](http://purl.obolibrary.org/obo/MONDO_0012081) (15q11q13 microduplication syndrome), [MONDO:0010507](http://purl.obolibrary.org/obo/MONDO_0010507) (Xq25 duplication syndrome), [MONDO:0010428](http://purl.obolibrary.org/obo/MONDO_0010428) (chromosome Xp11.23-p11.22 duplication syndrome), [MONDO:0014707](http://purl.obolibrary.org/obo/MONDO_0014707) (chromosome 14Q32 duplication syndrome, 700-Kb), [MONDO:0010467](http://purl.obolibrary.org/obo/MONDO_0010467) (Xq27.3q28 duplication syndrome), [MONDO:0017545](http://purl.obolibrary.org/obo/MONDO_0017545) (Zygodactyly type 4), [MONDO:0010491](http://purl.obolibrary.org/obo/MONDO_0010491) (X-linked acrogigantism due to Xq26 microduplication), [MONDO:0012351](http://purl.obolibrary.org/obo/MONDO_0012351) (Zygodactyly type 1), [MONDO:0017544](http://purl.obolibrary.org/obo/MONDO_0017544) (Zygodactyly type 3), [MONDO:0014235](http://purl.obolibrary.org/obo/MONDO_0014235) (chromosome 22q13 duplication syndrome), [MONDO:0013169](http://purl.obolibrary.org/obo/MONDO_0013169) (chromosome 5p13 duplication syndrome), [MONDO:0012574](http://purl.obolibrary.org/obo/MONDO_0012574) (Potocki-Luspski syndrome), [MONDO:0017543](http://purl.obolibrary.org/obo/MONDO_0017543) (Zygodactyly type 2), [MONDO:0013363](http://purl.obolibrary.org/obo/MONDO_0013363) (chromosome 2q31.1 duplication syndrome), [MONDO:0013182](http://purl.obolibrary.org/obo/MONDO_0013182) (chromosome 17p13.3 duplication syndrome), [MONDO:0008512](http://purl.obolibrary.org/obo/MONDO_0008512) (syndactyly type 1), [MONDO:0012915](http://purl.obolibrary.org/obo/MONDO_0012915) (chromosome 1q21.1 duplication syndrome), [MONDO:0013329](http://purl.obolibrary.org/obo/MONDO_0013329) (familial clubfoot due to 17q23.1q23.2 microduplication), [MONDO:0013847](http://purl.obolibrary.org/obo/MONDO_0013847) (chromosome 16p11.2 duplication syndrome), [MONDO:0010436](http://purl.obolibrary.org/obo/MONDO_0010436) (chromosome Xq28 duplication syndrome), 

**Mapped go classes:** [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005254](http://purl.obolibrary.org/obo/GO_0005254) (chloride channel activity), [GO:0006821](http://purl.obolibrary.org/obo/GO_0006821) (chloride transport), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0034707](http://purl.obolibrary.org/obo/GO_0034707) (chloride channel complex), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0060315](http://purl.obolibrary.org/obo/GO_0060315) (negative regulation of ryanodine-sensitive calcium-release channel activity), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody), [GO:0031489](http://purl.obolibrary.org/obo/GO_0031489) (myosin V binding), 

**Class expressions from DL-Learner:**

- [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport) 56.25%
- [GO:1901020](http://purl.obolibrary.org/obo/GO_1901020) (negative regulation of calcium ion transmembrane transporter activity) 56.25%
- [GO:0060315](http://purl.obolibrary.org/obo/GO_0060315) (negative regulation of ryanodine-sensitive calcium-release channel activity) 56.25%
- [GO:0031489](http://purl.obolibrary.org/obo/GO_0031489) (myosin V binding) 56.25%
- [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody) 56.25%
- [GO:0017022](http://purl.obolibrary.org/obo/GO_0017022) (myosin binding) 56.25%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 56.25%
- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 56.25%
- [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding) 56.25%
- [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity) 56.25%
- [GO:1901020](http://purl.obolibrary.org/obo/GO_1901020) (negative regulation of calcium ion transmembrane transporter activity) and [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity) 56.25%
- [GO:1901019](http://purl.obolibrary.org/obo/GO_1901019) (regulation of calcium ion transmembrane transporter activity) and [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity) 56.25%
- [GO:0060314](http://purl.obolibrary.org/obo/GO_0060314) (regulation of ryanodine-sensitive calcium-release channel activity) and [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity) 56.25%
- [GO:0032561](http://purl.obolibrary.org/obo/GO_0032561) (guanyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0032550](http://purl.obolibrary.org/obo/GO_0032550) (purine ribonucleoside binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%


